Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells
InChi: InChI=1S/C19H14N2O4/c22-17-13-6-1-2-7-14(13)18(23)21(17)16(19(24)25)9-11-10-20-15-8-4-3-5-12(11)15/h1-8
Everolimus also shows antiangiogenic/vascular effects in VEGF-induced HUVEC proliferation with IC50 of 0
WIN-55212-2 mesylate inhibition of 50 mm K+-evoked CGRP release is not reversed by antagonists of cannabinoid type 1 (CB1) receptor
ClH/c1-20-13-11-15(21-2)17(16(12-13)22-3)14(19)7-6-10-18-8-4-5-9-18
Efavirenz ne (dimaleate) Icaritin activates JNK-dependent mPTP necrosisEfavirenz is a non nucleoside reverse transcriptase inhibitor, NNRTI. Efavirenz is highly specific and potent allosteric inhibitors of HIV 1 reverse transcriptase. Efavirenz also inhibits the late stages of HIV 1 replication by interfering with HIV 1 Gag Pol polyprotein processing. It is used as part of highly active antiretroviral therapy for the treatment of a human immunodeficiency virus type 1. Product information CAS Number: 154598 52 4 Molecular
US$ 111.50
US$ 19.00
US$ 10.50
US$ 28.50
US$ 75.50
US$ 16.50
US$ 10.50
US$ 10.50
US$ 19.00